This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
HCPLive
FEBRUARY 2, 2024
Obesity was linked to an increased risk of focal segmental glomerulosclerosis and hypertensive nephropathy, with further analysis revealing its impact on the risk of developing end-stage kidney disease.
105 
Med Page Today
MARCH 15, 2024
(MedPage Today) -- A computerized clinical decision support (CDS) tool for primary care helped lower blood pressure (BP) in patients with chronic kidney disease (CKD) and uncontrolled hypertension, a cluster-randomized trial found. When primary.
116 
HCPLive
MARCH 26, 2025
Other risk factors in the population included PZA or ETB use, hypertension, heart failure, and chronic kidney disease.
112 
Cardiovascular Diabetology
APRIL 9, 2024
Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes and is often acc.
Hypertension Journal
DECEMBER 7, 2023
Hypertension, Ahead of Print. ETs were shown to play important roles among others, in systemic hypertension, particularly when resistant or difficult to control, and in pulmonary hypertension, atherosclerosis, cardiac hypertrophy, subarachnoid hemorrhage, chronic kidney disease, diabetic cardiovascular disease, scleroderma, some cancers, etc.
American College of Cardiology
FEBRUARY 5, 2024
Hypertension represents a major modifiable risk factor for coronary artery disease (CAD), heart failure (HF), stroke, chronic kidney disease (CKD), and dementia.
75 
CardiacWire
MAY 8, 2024
A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease. Stage 4 (heart disease, with or without kidney disease) – 9.2% in Whites).
116 
Journal of Clinical Investigation - Cardiology
JANUARY 2, 2024
Mineralocorticoid excess commonly leads to hypertension (HTN) and kidney disease. This gene signature also showed a potential for classifying human kidney samples. In our study, we used single-cell expression and chromatin accessibility tools to characterize the mineralocorticoid target genes and cell types.
132 
MIBHS
FEBRUARY 15, 2025
High blood pressure, also known as hypertension, is a common condition that affects millions of people worldwide. Often referred to as the silent killer, hypertension can quietly damage your heart and other vital organs over time. Hypertension is diagnosed when blood pressure consistently reads 130/80 mm Hg or higher.
DAIC
APRIL 9, 2025
Tryvio is Idorsias dual endothelin receptor antagonist (ERA) indicated for the treatment of systemic hypertension in combination with other antihypertensives to lower blood pressure in patients who are not adequately controlled on other drugs. Hypertension. The durable efficacy was achieved with a good safety and tolerability profile.
DAIC
JANUARY 8, 2025
a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S. tim.hodson Wed, 01/08/2025 - 14:11 Jan. 8, 2025 Mineralys Therapeutics, Inc.,
American College of Cardiology
MARCH 22, 2024
Does a computerized clinical decision support (CDS) system based on behavioral economic principles and human-centered design lead to a decrease in systolic blood pressure (SBP) in patients with chronic kidney disease (CKD) and uncontrolled hypertension?
52 
Hypertension Journal
SEPTEMBER 14, 2023
Hypertension, Volume 80, Issue 12 , Page 2533-2543, December 1, 2023. BACKGROUND:Hypertension frequently accompanies chronic kidney disease (CKD) as etiology and sequela.
Hypertension Journal
DECEMBER 5, 2024
Hypertension, Ahead of Print. BACKGROUND:Intensive blood pressure (BP) control in youth with chronic kidney disease (CKD) slows progression, delaying the need for kidney replacement therapy (KRT). Most youth with CKD have hypertension and BP control is difficult to achieve outside of controlled experimental settings.
Med Page Today
APRIL 3, 2024
(MedPage Today) -- Using a personalized algorithm to identify primary care patients with chronic kidney disease (CKD), type 2 diabetes, and hypertension (the kidney-dysfunction triad) -- plus practice facilitators to help providers deliver guideline.
Frontiers in Cardiovascular Medicine
APRIL 4, 2024
Hypertension is a leading cause of morbidity and mortality worldwide and poses a major risk factor for cardiovascular diseases and chronic kidney disease.
Stroke Journal
FEBRUARY 1, 2024
Introduction:Chronic kidney disease (CKD) is a well-established risk factor for spontaneous intracerebral hemorrhage (ICH). This association was reduced to a 19% increase in ICH risk after adjusting for hypertension in multivariable MR (OR 1.19; 95% CI 1.03-1.39; 1.71; p=0.002). 1.39; p=0.021).
Hypertension Journal
MARCH 6, 2025
Hypertension, Ahead of Print. BACKGROUND:Arterial hypertension (HTN) and type 2 diabetes (T2DM) are contributors to chronic kidney disease leading to glomerulomegaly and podocyte loss. Enlarged glomeruli and podocyte depletion are associated with kidney disease progression.
45 
Hypertension Journal
NOVEMBER 13, 2024
Hypertension, Volume 82, Issue 1 , Page 14-25, January 1, 2025. Podocyte dysfunction, resulting from oxidative stress, dysregulated prosurvival signaling, or structural damage, can drive the development of proteinuria and glomerulosclerosis in hypertensive nephropathy.
40 
Frontiers in Cardiovascular Medicine
DECEMBER 12, 2024
BackgroundThe association between healthy lifestyle and American Heart Association (AHA) Life's Essential 8 (LE8) score and apparent treatment-resistant hypertension(aTRH)remains uncertain. to 0.20) for uncontrolled hypertension with 12 and 34 antihypertensive drugs, respectively. to 0.76) and 0.07 (95% CI, 0.02
52 
Stroke Journal
JANUARY 30, 2025
Background:Chronic kidney disease (CKD) has emerged as an independent risk factor for cerebral microhemorrhages (CMH). Stroke, Volume 56, Issue Suppl_1 , Page ADP60-ADP60, February 1, 2025. adenine diet to induce CKD, or angiotensin II (ATII) via subcutaneous osmotic pumps to induce HTN and compared with control mice.
Circulation
MARCH 9, 2025
Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors. Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025.
HCPLive
JANUARY 8, 2025
Panelists discuss how chronic kidney disease (CKD) and uncontrolled hypertension create a damaging cycle, in which hypertension accelerates kidney damage while declining kidney function makes blood pressure harder to control.
HCPLive
DECEMBER 4, 2024
Panelists discuss how poor medication adherence and comorbidities such as chronic kidney disease (CKD) contribute to uncontrolled hypertension despite the availability of numerous treatment options, highlighting key challenges in achieving effective blood pressure management.
Hypertension Journal
FEBRUARY 22, 2024
Hypertension, Ahead of Print. Hypertension is one of the most commonly treated conditions in modern medical practice, but despite its long history, it was largely ignored until the midpoint of the 20th century.
40 
Journal of the American Heart Association
DECEMBER 1, 2023
Participants with an RHR of ≥80 bpm had a higher stage of chronic kidney disease, lower estimated glomerular filtration rate, and more proteinuria than those with an RHR of 60 to 69 bpm. Of the participants, 32.6% had an RHR of 60 to 69 beats per minute (bpm), and 22.2% had an RHR of ≥80 bpm. 1.42]) and 64% (HR, 1.64 [95% CI, 1.42–1.90])
75 
Hypertension Journal
NOVEMBER 1, 2023
Hypertension, Ahead of Print.
American College of Cardiology
FEBRUARY 18, 2025
A 65-year-old woman with a history of systemic lupus erythematosus (SLE) treated with prednisone and hydroxychloroquine 300 mg/day for 40 years, stage 3 chronic kidney disease, and hypertension presented to the cardiology clinic with progressive dyspnea on exertion.
Cardiometabolic Health Congress
NOVEMBER 16, 2023
Key findings presented at the conference included disparities in access to kidney transplantation and waitlisting based on race and neighborhood characteristics, racial and ethnic differences in incident chronic kidney disease (CKD), and the use of motivational strategies to improve dialysis nonadherence among African American patients.
Cardiometabolic Health Congress
NOVEMBER 25, 2024
Don’t worry—you can still access the 19th Annual CMHC sessions through our On-Demand platform, which offers 14 CME credits across four comprehensive tracks: Cardiorenal Health: Stay up-to-date with the latest on therapies for resistant hypertension, chronic kidney disease markers, and cardiac risk assessment tools.
52 
Stroke: Vascular and Interventional Neurology
MARCH 6, 2024
We aimed to define the prevalence of systemic hypertension in MMD patients and characterize its evolution after cerebral revascularization.METHODSPatients with MMD treated with extracranial‐intracranial bypass from 2014 to 2018 were retrospectively enrolled. 6.04]), kidney disease (OR, 18.98 [95% CI, 1.80–200.47]), respectively.
40 
Heart BMJ
OCTOBER 10, 2024
The association between AF and various conditions—including hypertension, heart failure, sleep apnoea and chronic kidney disease—is well-described, highlighting that AF is often a multisystem disorder. 2 Before the.
Cardiometabolic Health Congress
JULY 25, 2024
Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.
100 Open Heart
MARCH 23, 2023
Background Hypertension is a silent killer that causes serious health issues in all parts of the world. It is risk factor for cardiovascular disease, stroke and kidney disease. Self-monitoring practice has been identified as an important component of hypertension management. and then exported to SPSS V.25
Hypertension Journal
NOVEMBER 13, 2023
Hypertension, Ahead of Print. BACKGROUND:Polycystic kidney disease is the most common hereditary kidney disorder with early and frequent hypertension symptoms.
Circulation
NOVEMBER 11, 2024
Randomized controlled trials that were published between January 1st, 2013 and May 1st, 2023 that included hypertensive patients over 60 years old which reported major adverse cardiovascular outcomes (MACE) or all-cause mortality, cardiovascular mortality and safety outcomes were selected. of patients had cardiovascular disease, 10.9%
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
Background Preeclampsia (PE) is associated with subsequent higher risk of cardiovascular and kidney disease. Serum copeptin, as a proxy for vasopressin, and urinary uromodulin, were associated with PE physiopathology and kidney functional mass respectively.
Open Heart
JUNE 1, 2022
Survival was higher among the younger patients, and among those with hypertension or atrial fibrillation (AF). Mortality was increased with male gender, valvular heart disease and chronic kidney disease. Results From the SHEAF registry, we identified 1766 patients with raised NT-proBNP with no evidence of HF on TTE.
Hypertension Journal
DECEMBER 12, 2023
Hypertension, Ahead of Print. Failure of this process is a hallmark of hypertension, chronic kidney disease, heart failure, and other acute and chronic diseases. Homeostasis of fluid and electrolytes is a tightly controlled physiological process.
Dr. Malcolm Kendrick
DECEMBER 8, 2023
Here, for example, plucked at random, is a reference to the latest NICE guidelines on the management of hypertension (high blood pressure) in adults. But this, the primary guideline on hypertension for adults, is but one of many. There are associated guidelines on hypertension in pregnancy. 2 Have I read the entire document.
Circulation
NOVEMBER 11, 2024
Logistic regression was used to determine the association between 5-HTP levels and calcification severity, adjusting for age, gender, smoking status, chronic kidney disease, hyperlipidemia, and diabetes. to 1.63); hypertension 1.57 (0.87 to 2.31); chronic kidney disease 1.07 (0.33 95% CI = 2.6 to 40686.5).
Journal of the American Heart Association
MARCH 27, 2025
Among 9570 patients, 50% (n=4789) had multimorbidity.
European Journal of Heart Failure
NOVEMBER 23, 2023
Abstract Aims Transthyretin cardiac amyloidosis (ATTR-CA) is an infiltrative cardiomyopathy that commonly presents with concomitant chronic kidney disease. In a subgroup of patients (n = 349) without concomitant hypertension, diabetes mellitus or chronic kidney disease, albuminuria was also associated with mortality (HR=2.98, 95%CI[1.72-5.17],
Circulation
NOVEMBER 11, 2024
He was counseled to abstain from cannabis use.Conclusion:At low to moderate doses, cannabis can lead to a surge in sympathetic activity causing tachycardia and hypertension, while parasympathetic activity is predominant at higher doses, causing bradycardia and hypotension. Patient did not report any symptoms and was hemodynamically stable.
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content